跳至主要内容
临床试验/NCT03365700
NCT03365700Unknown不适用

Cryoballon Versus Conventional Radiofrequency Ablation for Persistent Atrial Fibrillation With AF Duration < 2 Years: the IRON-ICE Trial

Luigi Sacco University Hospital3 个研究点 分布在 1 个国家目标入组 303 人开始时间: 2018年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
303
试验地点
3
主要终点
Freedom from atrial tachycardia/fibrillation

研究概览

简要总结

A randomized trial has recently demonstrated non-inferiority of cryoballoon vs. radiofrequency (RF) catheter ablation in patients with drug-refractory paroxysmal atrial fibrillation (AF). There is a growing amount of evidence suggesting that Cryoballoon ablation is highly effective also in non-paroxysmal atrial fibrillation.

The IRON-ICE trial will evaluate the effect of Cryoballoon AF ablation in patients with short-term persistent AF.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Candidates for AF ablation based on AF that is symptomatic and refractory to at least one antiarrhythmic medication.
  • Patients presenting with Persistent AF with AF duration < 2 years scheduled to undergo a PVAI procedure
  • Age range of 18 - 85 years
  • Patients with already implanted devices with AF detection capabilities (for clinical indications): ILR implanted in the same hospital stay or within 6 months before the ablation or patients with an dual chamber PM, ICD or CRTD and an existing functional atrial lead.
  • Patients must be able and willing to provide written informed consent to participate in the clinical trial.

排除标准

  • Congenital heart disease, age younger than 18 years, significant valve disease, LA size >55 mm, and severe heart failure (ejection fraction < 30% and/or New York Heart Association class IV).
  • Presence of a mechanical prosthetic valve.
  • Secondary causes of atrial fibrillation
  • Documented intra-atrial thrombus or another abnormality which precludes catheter introduction.
  • Social factors that would preclude follow up or make compliance difficult.-
  • Patients who are or may potentially be pregnant Previous left atrial catheter ablation or MAZE procedure.

研究组 & 干预措施

Cryoballoon ablation

Active Comparator

Cryoballoon pulmonary vein isolation with the Arctic Front Advance® System or any future development generations of this product line.

干预措施: Cryoballoon ablation (Procedure)

Radiofrequency Ablation

Active Comparator

Contact force-sensing radiofrequency left atrial ablation with 3D mapping system.

干预措施: Radiofrequency Ablation (Procedure)

结局指标

主要结局

Freedom from atrial tachycardia/fibrillation

时间窗: 12 months

Freedom from atrial tachycardia/fibrillation within 12 months after CA. Arrhythmias had to last 30 seconds or more to be considered present.

次要结局

  • Length of postoperative hospital stay.(1 month)
  • Total procedural time.(1 day)
  • Significant reduction in AF burden(12 months)
  • Number of AF episodes recorded.(12 months)
  • Left atrial instrumentation time(1 day)
  • Incidence of cerebrovascular events from the time of the operation up to 90 days.(90 Days)
  • Death from any cause(12 months)
  • Low daily AF burden(12 months)
  • Duration of AF episodes recorded.(12 months)
  • Fluoroscopy time(1 day)
  • Procedure-related complications(1 week)
  • Long-term success(36 months)
  • Hospitalizations after discharge.(12 months)
  • Freedom from persistent AF/AFL/AT (duration cutoff of 7 days)(12 months)
  • Freedom from clinical or stroke-relevant AF/AFL/AT.(12 months)
  • Regression from persistent to non-paroxysmal atrial fibrillation(12 months)

研究者

发起方
Luigi Sacco University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giovanni B Forleo

Section Head Electrophysiology and Cardiac Pacing.

Luigi Sacco University Hospital

研究点 (3)

Loading locations...

相似试验